For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Vaxcyte Inc (NASDAQ: PCVX) closed at $44.85 down -2.56% from its previous closing price of $46.03. In other words, the price has decreased by -$2.56 from its previous closing price. On the day, 1.32 million shares were traded. PCVX stock price reached its highest trading level at $47.395 during the session, while it also had its lowest trading level at $44.53.
Ratios:
For a deeper understanding of Vaxcyte Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.83 and its Current Ratio is at 8.83. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on September 12, 2025, initiated with a Neutral rating and assigned the stock a target price of $38.
On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135.Goldman initiated its Buy rating on December 20, 2024, with a $135 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 31 ’25 when Dhaliwal Harpreet S. sold 9,743 shares for $46.69 per share. The transaction valued at 454,891 led to the insider holds 23,928 shares of the business.
HARPREET DHALIWAL bought 9,743 shares of PCVX for $454,893 on Dec 31 ’25. On Dec 23 ’25, another insider, Cowan Elvia, who serves as the SVP, FINANCE of the company, sold 11,623 shares for $47.92 each. As a result, the insider received 556,972 and left with 14,534 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 5871145984 and an Enterprise Value of 4244268800.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.33, which has changed by -0.43214905 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $93.77, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -1.80%, while the 200-Day Moving Average is calculated to be 17.72%.
Shares Statistics:
For the past three months, PCVX has traded an average of 1.49M shares per day and 1170960 over the past ten days. A total of 130.03M shares are outstanding, with a floating share count of 126.96M. Insiders hold about 3.01% of the company’s shares, while institutions hold 107.23% stake in the company. Shares short for PCVX as of 1765756800 were 10827314 with a Short Ratio of 7.26, compared to 1763078400 on 9336796. Therefore, it implies a Short% of Shares Outstanding of 10827314 and a Short% of Float of 9.25.
Earnings Estimates
. The current rating of Vaxcyte Inc (PCVX) is the result of assessments by 6.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$1.53, with high estimates of -$1.18 and low estimates of -$1.89.
Analysts are recommending an EPS of between -$4.19 and -$6.44 for the fiscal current year, implying an average EPS of -$5.31. EPS for the following year is -$6.22, with 6.0 analysts recommending between -$4.16 and -$7.9.
